Cook Jennifer E.: insider trades.
Cook Jennifer E. reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($13.2M), across 2 companies.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 2
- Companies
- 2
- Name as filed
- Cook Jennifer E.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | 5 |
| Jazz Pharmaceuticals plc (JAZZ) | Director | 3 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-31 | Jazz Pharmaceuticals plc | F | 14 | $244.06 | 12,428 | Form 4 |
| 2026-08-31 | Jazz Pharmaceuticals plc | F | 1,692 | $241.39 | 10,736 | Form 4 |
| 2026-08-05 | Jazz Pharmaceuticals plc | A | 1,605 | $0 | 12,442 | Form 4 |
| 2026-07-09 | BridgeBio Pharma, Inc. | S | 36,167 | $84 | 120,805 | Form 4 |
| 2026-07-09 | BridgeBio Pharma, Inc. | M | 17,167 | $16.75 | 156,972 | Form 4 |
| 2026-07-09 | BridgeBio Pharma, Inc. | M | 112,422 | $29 | 139,805 | Form 4 |
| 2026-07-09 | BridgeBio Pharma, Inc. | M | 19,000 | $8.45 | 27,383 | Form 4 |
| 2026-07-09 | BridgeBio Pharma, Inc. | S | 112,422 | $90 | 8,383 | Form 4 |
Questions
What stock did Cook Jennifer E. buy or sell?
Cook Jennifer E. reported 8 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 2 sales ($13.2M), across 2 companies.
Is Cook Jennifer E. the same person as other filers with this name?
This page covers SEC CIK 1754371 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/cook-jennifer-e-1754371.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.